Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antib...
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
The rapid evolution of cell and gene therapy (CGT) is driving unprecedented innovation in manufacturing, yet the adoption of new analytical and process technologies continues to lag behind....
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar...
Over the recent years, LNPs have paved new possibilities in the world of nanomedicine. From early stage research to clinical manufacturing, having accurate and comprehensive characterisation...
Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antib...
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
The rapid evolution of cell and gene therapy (CGT) is driving unprecedented innovation in manufacturing, yet the adoption of new analytical and process technologies continues to lag behind....
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar...
Over the recent years, LNPs have paved new possibilities in the world of nanomedicine. From early stage research to clinical manufacturing, having accurate and comprehensive characterisation...
AI is transforming how biomanufacturers operate, from raw material qualification to final purification. In this panel, practitioners at the intersection of AI and bioprocessing will explore...
As downstream bioprocessing enters a new era of complexity, resilience, and scrutiny, raw materials have moved from a supporting role to a strategic lever for success. In this opening keynot...
mRNA technologies have rapidly evolved into one of the most exciting and versatile classes of modern medicines, powering breakthroughs in vaccines and emerging therapies for metabolic, cardi...
In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichmen...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is excited to host the 9 th Annual Event in the Bioprocessing Virtual Event Series on March 31st, 2026! Bioprocessing, at its core, is the art and science of transforming raw materi...
Labroots is pleased to announce the 10th Annual Event in the 2026 Cannabis Sciences Virtual Event Series , taking place on April 14th, 2027 . This year’s program highlights the rapidly...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is pleased to announce the 9 th Annual Event in the 2026 Cannabis Sciences Virtual Event Series taking place on April 15th, 2026! The Cannabis Sciences planning committee will be pl...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is excited to host the 9 th Annual Event in the Bioprocessing Virtual Event Series on March 31st, 2026! Bioprocessing, at its core, is the art and science of transforming raw materi...
Labroots is pleased to announce the 10th Annual Event in the 2026 Cannabis Sciences Virtual Event Series , taking place on April 14th, 2027 . This year’s program highlights the rapidly...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is pleased to announce the 9 th Annual Event in the 2026 Cannabis Sciences Virtual Event Series taking place on April 15th, 2026! The Cannabis Sciences planning committee will be pl...
Amplify downstream bioprocesses with high-grade raw materials that matter Hosted by Thermo Fisher Scientific April 7 • Opens: 9:00 AM EST / 2:00 PM GMT In bioprocessing, raw materials&m...
Labroots is excited to host the 8 th Annual Event in the Bioprocessing Virtual Event Series on April 1st, 2026! Bioprocessing, at its core, is the art and science of transforming raw materia...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...